April 2019 - Page 5 of 9

TuesdayApr 16, 2019 10:38 am

Sugarmade Inc. (SGMD) and Hempistry Ink Supply Contract amid Boom in Kentucky Hemp Industry

Hemp industry’s growth exhibiting boom trends in wake of the 2018 Farm Bill’s passage, altering regulatory oversight of the plant Sugarmade is focusing efforts on supporting the nascent hemp industry with hydroponic growth supplies The company has also signed a supply agreement with Kentucky-based private hemp cultivator Hempistry to support Hempistry’s micropropagation work Micropropagation helps growers ensure plant quality by cloning “mother” plants that exhibit preferred genetic traits Hydroponic agriculture supplier Sugarmade Inc. (OTCQB: SGMD) is preparing to significantly expand its operations in the hemp cultivation industry following recent regulatory changes in the agriculture sector and a new agreement with…

MondayApr 15, 2019 1:06 pm

4 Benefits of Using Cannabis to Replace Your Depression Medication

Antidepressant medications have become more popular than ever. According to the American Psychology Association, the number of Americans treated with antidepressants has increased by 64% from 1999 to 2014. While there may be a number of factors contributing to the increased use of this category of drugs, its use does have some big downsides. The use of antidepressants is controversial because of their harsh side-effects, withdrawal difficulty, and even their overall effectiveness. People are now searching for alternatives to antidepressants, and are finding them in surprising places. One antidepressant alternative is gaining more popularity: cannabis. As cannabis becomes legal in more…

MondayApr 15, 2019 12:14 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing DehydraTECH Drug Delivery Platform, Innovative Products

Lexaria Bioscience is focusing on its pioneering DehydraTECH drug delivery technology The company boasts a portfolio of unique products Lexaria continues to conduct research regarding DehydraTECH technology for oral nicotine Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Lexaria is the only global company with patents issued for the oral delivery of all cannabinoids. The company has developed and out-licenses its innovative and cost-effective DehydraTECH drug delivery platform. This technology changes the way that edible cannabinoids enter the body. DehydraTECH delivery technology offers a viable and…

MondayApr 15, 2019 11:46 am

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Marks Ninth Consecutive Quarter of Revenue Growth

Wildflower Brands Inc. sees annualized revenues exceeding $1 million for online sales The company’s diverse brands service customers nationwide, totaling distribution in over 300 stores The CBD product market is estimated to grow to $22 billion by 2022 and $75 billion by 2030 Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a Vancouver-based cannabis company focused on developing and designing branded products in the cannabis sector, intends to become a global wellness leader through its strategic varied brands in the industry. Wildflower Brands recently achieved more than 300 percent organic growth in online sales since January 2018, seeing annualized revenues exceeding…

MondayApr 15, 2019 10:25 am

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Logs First Premium Cannabis Sales Grown in World-Class Cultivation Facility

2018 major milestones included launch of medicinal and recreational sales channels Company sold nearly 406 kilograms of premium cannabis, despite having only 20 percent of Kelowna 1 grow rooms operational during Q4 2018 Flowr optimizes yields, producing premium and ultra-premium cannabis products with a goal of no irradiation, to maximize profitability The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer of premium cannabis products, recently shared details of several milestones achieved during the fourth quarter of 2018 that included the company’s first recorded revenues, with nearly 260 kilograms of premium cannabis grown in-house during the period, despite only 20…

FridayApr 12, 2019 11:37 am

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Aiming to Provide Non-Irradiated Cannabis Products to Growing User Base

A majority of Canadian cannabis users identified quality and safety as top factors in choosing where to purchase cannabis Canada’s Shoppers Drug Mart is now the exclusive direct-to-patient online provider of FlowrRx products Flowr grows premium cannabis with a goal of non-irradiation using production methods that are expected to generate high crop yields at low operating costs Medicinal cannabis patients in Canada are rightly concerned about how cannabis products prescribed by their physicians are produced. According to Canada’s national statistical agency, Statistics Canada, 76 percent of medical cannabis patients responding to the Q4 2018 ‘National Cannabis Survey’ identified quality and…

FridayApr 12, 2019 10:22 am

VPR Brands, LP (VPRB) Riding Rising Tide of Vaping Product Popularity with Lifestyle Brands

Vaping is growing in popularity in the United States and internationally, driving cannabis concentrate sales toward a forecast reach of $47.11 billion by 2025 VPR Brands has built on the successful acquisition of Vapor Corp. technologies and has recently been growing into the cannabidiol (CBD) derivatives space VPR Brands’ GoldLine Hemp products are also finding a niche in the convenience store market as a variety of CBD-free hemp edibles Vaporizers and e-cigarettes have been enjoying growing popularity in recent years, becoming the largest driver behind cannabis concentrate sales and maintaining a position as the second-largest marijuana product category in the…

FridayApr 12, 2019 9:58 am

This Week in Cannabis: Florida Patients Rightfully Upset Over Latest Medical Cannabis Measure

It was another big week for cannabis news. Some progress, lots of drama, and major developments to keep your eye on... Is a cap on THC coming to Florida's medical cannabis program? What happened: A committee in Florida's House of Representatives passed a measure that would cap cannabis flower's potency at 10%. The bill now moves to the House floor where it's unclear at this time what the chances are of it passing. Why it matters: The battle to allow sales of cannabis flower went on for a long time in Florida, with Florida's Governor lifting the ban on cannabis…

ThursdayApr 11, 2019 11:01 am

Global Consortium Inc. (GCGX) Establishes New Nutraceuticals Line, Explores Taking One Division Public in Canada

GCGX is a diversified cannabis holding company with $100 million in projected revenue for 2019 The company’s nutraceuticals division is to be overseen by medical physicians and veterinarians focused on diverse specialties GCGX’s product line is developed with proprietary infused formulas to include lotions, balms, ointments, liquids, pills and powders Discussions are underway to take one of the company’s divisions public in Canada in order to raise capital and open up growth potential From its headquarters in Florida, Global Consortium Inc. (OTC: GCGX), a diversified cannabis holding company expanding its reach nationwide with several subsidiaries, is evaluating an opportunity to…

ThursdayApr 11, 2019 10:32 am

Should You Be Worried About Cannabis Use Causing Psychosis?

Claims that cannabis use causes psychosis and other mental health problems is not a new phenomenon. From the very beginning of the push to prohibit cannabis, opponents have tried very hard to portray cannabis use as being an extremely risky behavior. The results of a new study were released recently in which cannabis was associated with increased chances of psychosis. Should cannabis consumers be worried? What did the recent study say? Researchers conducted a case-control study across ten European and one Brazilian site which looked at whether there's an association between high-potency cannabis and increased psychosis rates. The researchers concluded: "Cannabis use…

News and publishing service for hemp related companies

Contact us: 512.354.7000

Month: April 2019